JP2002540208A5 - - Google Patents

Download PDF

Info

Publication number
JP2002540208A5
JP2002540208A5 JP2000608013A JP2000608013A JP2002540208A5 JP 2002540208 A5 JP2002540208 A5 JP 2002540208A5 JP 2000608013 A JP2000608013 A JP 2000608013A JP 2000608013 A JP2000608013 A JP 2000608013A JP 2002540208 A5 JP2002540208 A5 JP 2002540208A5
Authority
JP
Japan
Prior art keywords
group
formula
alkyl
alkoxy
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000608013A
Other languages
English (en)
Japanese (ja)
Other versions
JP4500454B2 (ja
JP2002540208A (ja
Filing date
Publication date
Priority claimed from FR9903934A external-priority patent/FR2791678B1/fr
Application filed filed Critical
Publication of JP2002540208A publication Critical patent/JP2002540208A/ja
Publication of JP2002540208A5 publication Critical patent/JP2002540208A5/ja
Application granted granted Critical
Publication of JP4500454B2 publication Critical patent/JP4500454B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000608013A 1999-03-30 2000-03-21 1,4−ジアザビシクロ[3.2.2]ノナン−4−カルボキシレートおよびカルボキサミド誘導体、治療におけるその製造ならびに使用 Expired - Fee Related JP4500454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/03934 1999-03-30
FR9903934A FR2791678B1 (fr) 1999-03-30 1999-03-30 Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
PCT/FR2000/000697 WO2000058311A1 (fr) 1999-03-30 2000-03-21 Derives de 1,4-diazabicyclo[3.2.2]nonane-4-carboxylates et carboxamides, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
JP2002540208A JP2002540208A (ja) 2002-11-26
JP2002540208A5 true JP2002540208A5 (https=) 2006-09-14
JP4500454B2 JP4500454B2 (ja) 2010-07-14

Family

ID=9543787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000608013A Expired - Fee Related JP4500454B2 (ja) 1999-03-30 2000-03-21 1,4−ジアザビシクロ[3.2.2]ノナン−4−カルボキシレートおよびカルボキサミド誘導体、治療におけるその製造ならびに使用

Country Status (15)

Country Link
US (1) US6987106B1 (https=)
EP (1) EP1165559B1 (https=)
JP (1) JP4500454B2 (https=)
AR (1) AR023188A1 (https=)
AT (1) ATE232865T1 (https=)
AU (1) AU3301800A (https=)
CO (1) CO5180557A1 (https=)
DE (1) DE60001451T2 (https=)
DK (1) DK1165559T3 (https=)
ES (1) ES2192520T3 (https=)
FR (1) FR2791678B1 (https=)
PE (1) PE20001600A1 (https=)
TW (1) TWI221843B (https=)
UY (1) UY26082A1 (https=)
WO (1) WO2000058311A1 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003534344A (ja) 2000-05-25 2003-11-18 ターガセプト,インコーポレイテッド ニコチン性コリン受容体リガンドとしてのヘテロアリールジアザビシクロアルカン
US6624167B1 (en) 2000-08-04 2003-09-23 Targacept, Inc. Pharmaceutical compositions and methods for use
DE60216830T2 (de) * 2001-02-06 2007-06-14 Pfizer Products Inc., Groton Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
SE0202465D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202430D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
MXPA05003317A (es) 2002-09-25 2005-07-05 Memory Pharm Corp Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
MXPA05006861A (es) 2003-02-27 2005-12-12 Neurosearch As Derivados arildiazabiciclicos novedosos.
DE602004010299T2 (de) 2003-12-22 2008-09-18 Memory Pharmaceuticals Corp. Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen
CN100445285C (zh) * 2003-12-22 2008-12-24 阿斯利康(瑞典)有限公司 烟碱性乙酰胆碱受体配体
TW200529860A (en) * 2003-12-22 2005-09-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
EP1713810B1 (en) * 2004-02-04 2010-12-29 NeuroSearch A/S Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
NZ550534A (en) 2004-03-25 2009-07-31 Memory Pharm Corp Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
WO2006001894A1 (en) 2004-04-22 2006-01-05 Memory Pharmaceutical Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
JP2007538011A (ja) * 2004-05-07 2007-12-27 メモリー・ファーマシューティカルズ・コーポレイション 1h−インダゾール、ベンゾチアゾール、1,2−ベンゾイソキサゾール、1,2−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用
EP1802616B1 (en) * 2004-10-15 2011-01-12 NeuroSearch A/S Novel azabicyclic aryl derivatives and their medical use
RU2418797C2 (ru) 2004-12-22 2011-05-20 Мемори Фармасьютиклз Корпорейшн Лиганды никотинового рецептора альфа-7, их получение и применение
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
AU2007216531A1 (en) * 2006-02-14 2007-08-23 Neurosearch A/S Novel diazabicycloalkane derivatives and their medical use
JP2007217370A (ja) * 2006-02-17 2007-08-30 Nard Inst Ltd ポジトロン断層撮影法および該方法に用いるポジトロン放出化合物
WO2007135120A1 (en) 2006-05-23 2007-11-29 Neurosearch A/S Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
US20100234349A1 (en) 2006-09-04 2010-09-16 Olsen Gunnar M Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
WO2008119710A1 (en) * 2007-03-30 2008-10-09 Neurosearch A/S Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
FR2931823B1 (fr) 2008-06-02 2012-08-17 Sanofi Aventis Sel de fumarate du 1,4-diazabicyclo°3.2.2!nonane-carboxylate de 4-bromophenyle, ses formes cristallines, leur preparation et leur utilisation en therapeutique
FR2931677B1 (fr) * 2008-06-02 2010-08-20 Sanofi Aventis Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs
KR20180011888A (ko) 2008-11-19 2018-02-02 포럼 파마슈티칼즈 인크. (r)-7-클로로-n-(퀴누클리딘-3-일)벤조[b]티오펜-2-카르복사미드 및 그 약학적으로 허용가능한 염을 이용한 인지 장애의 치료
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
PE20120324A1 (es) * 2009-05-11 2012-04-17 Envivo Pharmaceuticals Inc Combinacion que comprende (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y donezepilo como moduladora de trastornos cognitivos
AR081402A1 (es) 2010-05-17 2012-08-29 Envivo Pharmaceuticals Inc Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida monohidrato
AU2012231275A1 (en) 2011-03-18 2013-10-17 Genzyme Corporation Glucosylceramide synthase inhibitors
CA2872005A1 (en) 2012-05-08 2013-11-14 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
MA37975B2 (fr) 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
CN107188900B (zh) * 2017-05-27 2019-09-06 北京师范大学 α7烟碱型乙酰胆碱受体的配体化合物及其应用
CN114040762A (zh) 2019-02-04 2022-02-11 建新公司 使用葡糖神经酰胺合酶(gcs)的抑制剂治疗纤毛疾病
TW202142236A (zh) 2020-02-03 2021-11-16 美商健臻公司 用於治療與溶體儲積症相關的神經症狀之方法
KR20230043024A (ko) 2020-07-24 2023-03-30 젠자임 코포레이션 벤글루스타트를 포함하는 제약 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235878A3 (en) * 1986-01-16 1989-06-14 Beecham Group Plc Novel compounds
JP2668670B2 (ja) * 1995-03-24 1997-10-27 日本たばこ産業株式会社 ジアザビシクロ[3.3.1]ノナン誘導体、その中間体及びその医薬用途
PT994875E (pt) * 1997-06-30 2004-06-30 Targacept Inc Derivados de 3-piridil-1-aza-biciclo-alcano para a prevencao e tratamento de desordens do snc

Similar Documents

Publication Publication Date Title
JP2002540208A5 (https=)
JP2004516314A5 (https=)
JP2003528918A5 (https=)
JP2002543065A5 (https=)
CA2436846A1 (en) Thioether substituted imidazoquinolines
JP2002513793A5 (https=)
JP2003500442A5 (https=)
JP2002517491A5 (https=)
JP2002502874A5 (https=)
JP2003519676A5 (https=)
JP2010514786A5 (https=)
JP2006500370A5 (https=)
JP2002539181A5 (https=)
JP2004524316A5 (https=)
JP2005536503A5 (https=)
JP2008512408A5 (https=)
JP2005530852A5 (https=)
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
JP2005517677A5 (https=)
JP2004525178A5 (https=)
JP2010535706A5 (https=)
JP2002506864A5 (https=)
RU2003130644A (ru) Производные ркарболина и их фармацевтическое применение против дипрессии и страха
JP2005516898A5 (https=)
JP2004538314A5 (https=)